For example, it would be beneficial to perform joint pharmacogenetic typing of G6PD along with CYP2D6 when considering Vivax malaria control with primaquine, as G6PD deficiency can result in primaquine-induced hemolysis35. This evidence concerns the gene G6PD and malaria.